Inside our research, we were being in the position to drastically escalate the dose of CX-5461 beyond that reached in the initial-in-human analyze in individuals with hematologic cancers. The RP2D of 475 mg/m2 on times 1, eight, and fifteen of a 4-week cycle, was determined by phototoxicity,